|Articles|November 1, 1998

November 1998
Volume 4
Issue 11

Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

Author(s)Michael E. Minshall, MPH, Astra M. Liepa, PharmD

Download PDF: Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

Articles in this issue

almost 28 years ago

Article

Discontinuity of Care: Urgent Care Utilization Within a Health Maintenance Organization

almost 28 years ago

Article

Explaining Price Variations for the Inpatient Treatment of Congestive Heart Failure

almost 28 years ago

Article

Consequences of Intermittent Treatment for Hypertension: The Case for Medication Compliance and Persistence

almost 28 years ago

Article

The Ethical Dilemma of Population-Based Medical Decision Making

almost 28 years ago

Article

Efficacy, Safety, and Impact on Quality of Life of Salmeterol in Patients With Moderate Persistent Asthma

almost 28 years ago

Article

Ventricular Arrhythmias and the Use of Antiarrhythmic Drugs After Cardiovascular Surgery

almost 28 years ago

Article

Methods of Evaluation in Outcomes Research

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

Sarcoma Gene Signature May Predict Who Benefits From Pazopanib

Lifestyle Factors Offer Actionable Targets in MASLD Management: Zobair M. Younossi, MD

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care